ARSENIC TRIOXIDE FOR INJECTION
As listed in the register: ARSENIC TRIOXIDE FOR INJECTION
2 mg · solution
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Arsenic Trioxide
- Made by
- Auro Pharma Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Arsenic Trioxide). It describes the substance, not this exact product.
The mechanism of action of arsenic trioxide is not completely understood.
Arsenic trioxide causes morphological changes and DNA fragmentation characteristic of apoptosis in NB4 human promyelocytic leukemia cells in vitro.
Approximately 15% of the administered arsenic trioxide dose is excreted in the urine as unchanged As III.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-11-07
Safety of the active substance
From the US prescribing label for the same active substance (Arsenic Trioxide). It describes the substance, not this exact product.
WARNING: DIFFERENTIATION SYNDROME, CARDIAC CONDUCTION ABNORMALITIES, and ENCEPHALOPATHY INCLUDING WERNICKE'S Differentiation Syndrome: Patients with acute promyelocytic leukemia (APL) treated with arsenic trioxide have experienced differentiation syndrome, which may be life-threatening or fatal.
- Arsenic trioxide is contraindicated in patients with hypersensitivity to arsenic.
- Hypersensitivity to arsenic.
The most common adverse reactions (>30%) were nausea, cough, fatigue, pyrexia, headache, abdominal pain, vomiting, tachycardia, diarrhea, dyspnea, hypokalemia, leukocytosis, hyperglycemia, hypomagnesemia, insomnia, dermatitis, edema, QTc prolongation, rigors, sore throat, arthralgia, paresthesia, and pruritus.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Auro Pharma Inc |
|---|---|
| Active substance | Arsenic Trioxide |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 2 mg |
| Form | solution |
| Classification | L01XX27 · Cancer treatments and immune-system medicines |
| Route | intravenous |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Approved |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02540517 |
| DPD drug code | 102921 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution5 products
1 mg2
1 mg · 2 companies
2 mg2
2 mg · 2 companies
- Auro Pharma Inc · this page
- Eugia Pharma Inc.
- 10 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.